Back

Gymnema Sylvestre

Reducing sugar cravings and post-meal glucose

Evidence · Grade DSafety · Use with caution
Human trial evidenceTraditional useSafety cautionInteraction riskNeeds more research

An Ayurvedic herb known as the "sugar destroyer" for blunting sweet cravings and blood sugar spikes.

Gymnema sylvestre is a woody climbing shrub used in Ayurvedic medicine for over 2000 years to manage what was called "honey urine" (diabetes).

Quick answer

What it is: Gymnema sylvestre is a woody climbing shrub used in Ayurvedic medicine for over 2000 years to manage what was called "honey urine" (diabetes).

May support:Metabolic Syndrome, Prediabetes, Insulin Resistance, Obesity, Type 1 Diabetes, Type 2 Diabetes

Evidence:Evidence · Grade D

Safety:Safety · Use with caution

Evidence Summary

Evidence · Grade D

The 'C' evidence grade is primarily supported by a mix of preclinical studies, small human trials, and some observational data. While there are a few randomized controlled trials, many are limited in size and duration. The traditional use of Gymnema also contributes to continued interest and investigation into its properties.

Last reviewed · Jun 2026

Have you tried Gymnema Sylvestre?

Vote in 5 seconds. Add details if you want.

Your experience for Metabolic Syndrome:

Commonly Combined With

Other remedies frequently used alongside this one — from curated relationships, community reports, and shared protocols.

Community signal breakdown

Where this remedy is being discussed across the web and community.

People Like Me insights

As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.

Community Discussions

What people say about Gymnema Sylvestre

Search on Reddit →

Latest News

Latest news on Gymnema Sylvestre

More on Google News →

Health Videos

Health videos on Gymnema Sylvestre

More on YouTube

Why It Works

Gymnemic acids block sweet taste receptors and may reduce intestinal glucose absorption and support beta-cell regeneration.

How it works in more detail

Gymnema sylvestre is studied for its potential role in glucose metabolism. It appears to interact with taste receptors on the tongue, temporarily suppressing the perception of sweetness. Preclinical and some human studies suggest that gymnemic acids, active compounds in Gymnema, may inhibit glucose absorption in the intestine and support pancreatic beta-cell function, potentially influencing insulin secretion. It may also play a role in lipid metabolism, though more research is needed to elucidate specific pathways. These effects are thought to involve enzyme modulation and receptor binding.

How to use

Always consult a qualified clinician.

Editorial guidance

Suggested dosage
200–400 mg standardized extract (25% gymnemic acids), 2x daily
Frequency
Once daily
With or without food
Before meals

To reduce glucose absorption from the intestine

Research dosage range
200–600 mg/day of an extract standardized to 25% gymnemic acids, or 2–4 grams of dried leaf powder per day.
Typical onset
Some acute effects, such as sweetness suppression, may be noticed relatively quickly. However, systemic effects on glucose metabolism are typically reported after several weeks to months of consistent use.
Typical forms
Capsule, Tablet, Powder, Tea
Quality markers
A quality Gymnema sylvestre product should ideally be standardized to a specific percentage of gymnemic acids, often around 25%. Look for products that have undergone third-party testing for purity and potency. Organic certification and clear sourcing information can also indicate a higher quality product.
Medication interactions
  • Antidiabetic medications (may enhance effects, leading to hypoglycemia)
Avoid if
  • Pregnant or breastfeeding
  • Known allergy to Asclepiadaceae family plants
  • Undergoing surgery (discontinue at least two weeks prior)

Community tips

No community tips yet — be the first to share what worked for you.

Suggested dosage

200–400 mg standardized extract (25% gymnemic acids), 2x daily

Active medicinal compounds

Gymnemic acids, gymnemasaponins, anthraquinones, stigmasterol, and triterpenoid saponins.

Traditional use

Gymnema sylvestre, known as 'sugar destroyer' in Hindi, has a long history of use in Ayurvedic medicine. It was traditionally employed for various ailments, particularly those related to blood sugar imbalances and digestive issues. Folk medicine practices have also utilized its leaves for similar purposes.

Safety

Safety warnings

May cause hypoglycemia when combined with diabetes medications. Avoid in pregnancy.

Avoid if

  • Pregnant or breastfeeding
  • Known allergy to Asclepiadaceae family plants
  • Undergoing surgery (discontinue at least two weeks prior)

Medication interactions

  • Antidiabetic medications (may enhance effects, leading to hypoglycemia)

Reported side effects

  • Mild gastrointestinal upset
  • Nausea
  • Diarrhea
  • Abdominal pain

Evidence ecosystem

Scientific literature, clinical guidance, government sources, ongoing research, traditional use, and lived experience — grouped by source type and quality.

Overall grade (D)

The 'C' evidence grade is primarily supported by a mix of preclinical studies, small human trials, and some observational data. While there are a few randomized controlled trials, many are limited in size and duration. The traditional use of Gymnema also contributes to continued interest and investigation into its properties.

Filter by source type

Observational Studies(1)

Cohort, case-control, and cross-sectional human studies.

Moderate Quality
  • Algorithm for complementary and alternative medicine practice and research in type 2 diabetes.

    Bradley R, Oberg EB, Calabrese C, Standish LJ · Journal of alternative and complementary medicine (New York, N.Y.) · 2007

    To develop a model to direct the prescription of nutritional and botanical medicines in the treatment of type 2 diabetes for both clinical and research purposes. Available literature on nutritional and botanical medicines was reviewed and categorized as follows: antioxidant/anti-inflammatory; insulin sensitizer; and beta-cell protectant/insulin secretagogue. Literature describing laboratory assessment for glycemic control, insulin resistance, and beta-cell reserve was also reviewed and a clinical decision tree was developed. Clinical algorithms were created to guide the use of nutritional and botanic medicines using validated laboratory measures of glycemic control, insulin sensitivity, and beta-cell reserve. Nutrient and botanic medicines with clinical trial research support include coenzyme Q10, carnitine, alpha-lipoic acid, N-acetylcysteine, vitamin D, vitamin C, vitamin E, chromium, vanadium, omega-3 fatty acids, cinnamon (Cinnamomum cassia), fenugreek (Trigonella foenum-graecum)

    Observational StudyPubMedLow Quality

Clinical Trial Registries(1)

Registered ongoing or completed trials (ClinicalTrials.gov).

Moderate Quality
  • Effect of the Administration of Gymnema Sylvestre on Glycemic Control, Insulin Secretion and Insulin Sensitivity in Patients With Impaired Glucose Tolerance.

    n=30 · NCT02708966 · COMPLETED · COMPLETED

    Prediabetes (PD) was defined as an state in which glucose levels are above normal but not enough to meet criteria for the diagnosis of type 2 diabetes (T2D). PD can be presented as impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and glycated hemoglobin A1c (A1C) altered. The International Diabetes Federation (IDF) reported that in 2013 the prevalence of IGT was 6.9% which is equivalent to approximately 316 million individuals with IGT, it is expected that by 2035 this number will increase to 417 million people affected. Many hypoglycemic effects attributed to Gymnema sylvestre have been reported, including: increase of insulin secretion, regeneration of pancreatic islet cells, increased glucose utilization in various ways and inhibition of glucose uptake in the intestine.

    Clinical TrialClinicalTrials.govModerate Quality

Limitations: Current evidence is limited by the small sample sizes and heterogeneity of many human clinical trials. There is a need for larger, longer-term, double-blind, placebo-controlled studies to confirm efficacy and determine optimal dosages. Furthermore, potential conflicts of interest in some published research cannot be entirely ruled out.

This page is educational. Statements use phrases like "may support" and "has been studied for"because no remedy here is approved to cure, treat, or reverse any condition. Discussion happens on the ailment pages — community statistics here are derived from those reports. Always consult a qualified clinician.

Tried Gymnema Sylvestre?

Help others see what actually works.